Not applicableStudy completedNCT00002405What this trial is testingAmprenavir in HIV-Infected PatientsWho this might be right forHIV Infections Glaxo Wellcome
Large-scale testing (Phase 3)Study completedNCT00242801What this trial is testingIressa vs Best Supportive Care - 2nd/3rd Line Survival StudyWho this might be right forNSCLC AstraZeneca 1,692
Large-scale testing (Phase 3)Ended earlyNCT02117479What this trial is testingStudy of Ruxolitinib in Pancreatic Cancer Patients (Janus 1)Who this might be right forPancreatic Cancer Incyte Corporation 321
Testing effectiveness (Phase 2)Looking for participantsNCT06764017What this trial is testingCHiR Therapy for Elderly DLBCL Intolerant to ChemoWho this might be right forDiffuse Large B-Cell Lymphoma First Affiliated Hospital of Ningbo University 30
Testing effectiveness (Phase 2)Enrolling By InvitationNCT06260553What this trial is testingMetronomic Oral Vinorelbine Combination With Tislelizumab in EGFR/ALK-negative Advanced NSCLCWho this might be right forEGFR/ ALK-negative Advanced NSCLC Fujian Cancer Hospital 40
Very early researchLooking for participantsNCT06496373What this trial is testingClinical Study of mRNA Vaccine Combined With PD-1 Inhibitor as Adjuvant Therapy for Postoperative Pancreatic CancerWho this might be right forPancreatic Cancer ResectableChemotherapy-intolerant Ruijin Hospital 20
Testing effectiveness (Phase 2)UnknownNCT01356875What this trial is testingTreatment of Myelodysplastic Syndromes Comparing Hydralazine/Ac. Valproic and Supportive Care in Patients Not Candidates, Refractory and/or Intolerant to Intensive ChemotherapyWho this might be right forMyelodysplastic Syndrome Basque Health Service 42
Not applicableStudy completedNCT00002417What this trial is testingAmprenavir in Patients With Protease Inhibitor-Related ComplicationsWho this might be right forHIV Infections Glaxo Wellcome
Testing effectiveness (Phase 2)Study completedNCT03833661What this trial is testingM7824 Monotherapy in Locally Advanced or Metastatic Second Line (2L) Biliary Tract Cancer (Cholangiocarcinoma and Gallbladder Cancer)Who this might be right forBiliary Tract CancerCholangiocarcinomaGallbladder Cancer EMD Serono Research & Development Institute, Inc. 159
Early research (Phase 1)Study completedNCT01820624What this trial is testingLithium Carbonate and Tretinoin in Treating Patients With Relapsed or Refractory Acute Myeloid LeukemiaWho this might be right forAdult Acute Megakaryoblastic Leukemia (M7)Adult Acute Monoblastic Leukemia (M5a)Adult Acute Monocytic Leukemia (M5b)+11 more Paolo Caimi, MD 12
Testing effectiveness (Phase 2)Ended earlyNCT04501614What this trial is testingPonatinib With Chemotherapy in Children, Teenagers, and Adults With Philadelphia Chromosome-Positive Acute Lymphoblastic LeukemiaWho this might be right forPediatric Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia (Ph+ALL)Ph+ Mixed Phenotype Acute Leukemia (MPAL)Philadelphia Chromosome-Like ALL (Ph-like ALL) Takeda 11
Large-scale testing (Phase 3)Looking for participantsNCT06435429What this trial is testingA Study Comparing the Efficacy and Safety of Zanidatamab to Trastuzumab, Each in Combination With Physician's Choice Chemotherapy, for the Treatment of Participants With Metastatic HER2-positive Breast CancerWho this might be right forMetastatic HER2-positive Breast Cancer Jazz Pharmaceuticals 550
Testing effectiveness (Phase 2)UnknownNCT04994236What this trial is testingHepatic Artery Infusion Chemotherapy for Unresectable Hepatocelluar Carcinoma Who Failed to Systemic TherapyWho this might be right forHepatocellular Carcinoma Hui-Chuan Sun 49
Testing effectiveness (Phase 2)Ended earlyNCT01602315What this trial is testingA Phase Ib/II Study of BYL719 and Cetuximab in Recurrent or Metastatic Head and Neck Squamous Cell CarcinomaWho this might be right forRecurrent Head and Neck Squamous Cell CarcinomaMetastatic Head and Neck Squamous Cell Carcinoma Novartis Pharmaceuticals 179
Very early researchNot Yet RecruitingNCT07335094What this trial is testingA Clinical Study of Humanized CD19 CAR-T Cells With TLR2 for the Treatment of Adult Patients With Naive B-Cell Acute Lymphoblastic Leukemia/Lymphoma Who Are Intolerant to Intensive ChemotherapyWho this might be right forB Lymphoblastic Leukemia/Lymphoma Zhujiang Hospital 60
Testing effectiveness (Phase 2)Looking for participantsNCT06758037What this trial is testingClinical Study of HiR+X Therapy for Newly Diagnosed Elderly Patients with DLBCL Intolerant to ChemotherapyWho this might be right forDLBCLDiffuse Large B-Cell Lymphoma First Affiliated Hospital of Ningbo University 50
Not applicableLooking for participantsNCT05701735What this trial is testingDecision Aid for Chemotherapy in Cisplatin-Intolerant Patients With Locally Advanced Cervical CancerWho this might be right forLocally Advanced Cervical Carcinoma University of Santo Tomas Hospital, Philippines 45
Testing effectiveness (Phase 2)Study completedNCT03274882What this trial is testingStudy of Efficacy and Safety of S 95005 (TAS-102) in Patients With Metastatic Colorectal Cancer Who Failed Standard ChemotherapiesWho this might be right forMetastatic Colorectal Cancer Institut de Recherches Internationales Servier 26
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06669143What this trial is testingZanubrutinib-based Maintenance Therapy of Newly Diagnosed DLBCL With Initial RemissionWho this might be right forDiffuse Large B Cell Lymphoma Ruijin Hospital 19
Testing effectiveness (Phase 2)Ended earlyNCT02150967What this trial is testingA Phase II, Single Arm Study of BGJ398 in Patients With Advanced CholangiocarcinomaWho this might be right forAdvanced CholangiocarcinomaFGFR2 Gene Mutation QED Therapeutics, a BridgeBio company 143